Segantii Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Segantii Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,900	Closed	-$25K	–	410
2016 Q4	$25K	Buy	+4,900	New	+$23K	0.01%	112

Other funds holding DSCI

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Segantii Capital Management's DSCI Position: Q1 2017 in Review

Segantii Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 4,900 shares — an estimated $25K sold.

Segantii Capital Management first reported a position in DSCI in Q4 2016 and held it in 1 quarter. The position peaked at $25K in Q4 2016. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

Segantii Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
Segantii Capital Management sold 4,900 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $25K.
Segantii Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q4 2016 and held it in 1 quarter.
Segantii Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $25K in Q4 2016.
1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Segantii Capital Management's 13F filing for Q1 2017, filed 12 May 2017.